Respiratory Syncytial Virus, the pending task

1

Authors

DOI:

https://doi.org/10.37980/im.journal.rspp.20242428

Keywords:

Respiratory syncytial virus monoclonal, vaccine

Abstract

According to data from the Epidemiology Service of the  Hospital del Niño Doctor José Renán Esquivel (Panama), in the last 3 years, RSV has been the cause of 4.7 to 10.5% of all admissions, accounting for 61% of the cases. in children under 1 year of age; The fatality rate for 2023 was 1.2%. Meanwhile, until August 2024 there are 514 confirmed hospitalized cases of RSV and 10 deaths (fatality +/-1.9%)

Downloads

Published

2024-08-31

Issue

Section

Editorial